Luxbright AB (LXB) - Net Assets
Based on the latest financial reports, Luxbright AB (LXB) has net assets worth Skr26.89 Million SEK (≈ $2.89 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr39.38 Million ≈ $4.24 Million USD) and total liabilities (Skr12.49 Million ≈ $1.34 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read LXB total debt and obligations for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr26.89 Million |
| % of Total Assets | 68.29% |
| Annual Growth Rate | 27.42% |
| 5-Year Change | 30.37% |
| 10-Year Change | N/A |
| Growth Volatility | 106.69 |
Luxbright AB - Net Assets Trend (2015–2025)
This chart illustrates how Luxbright AB's net assets have evolved over time, based on quarterly financial data. Also explore Luxbright AB balance sheet assets for the complete picture of this company's asset base.
Annual Net Assets for Luxbright AB (2015–2025)
The table below shows the annual net assets of Luxbright AB from 2015 to 2025. For live valuation and market cap data, see Luxbright AB (LXB) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Skr26.89 Million ≈ $2.89 Million |
-21.35% |
| 2024-12-31 | Skr34.20 Million ≈ $3.68 Million |
+1.52% |
| 2023-12-31 | Skr33.69 Million ≈ $3.63 Million |
+20.89% |
| 2022-12-31 | Skr27.86 Million ≈ $3.00 Million |
+35.07% |
| 2021-12-31 | Skr20.63 Million ≈ $2.22 Million |
-46.60% |
| 2020-12-31 | Skr38.64 Million ≈ $4.16 Million |
+267.91% |
| 2019-12-31 | Skr10.50 Million ≈ $1.13 Million |
+52.20% |
| 2018-12-31 | Skr6.90 Million ≈ $742.52K |
+216.06% |
| 2017-12-31 | Skr-5.94 Million ≈ $-639.77K |
-791.08% |
| 2016-12-31 | Skr-667.16K ≈ $-71.80K |
-128.00% |
| 2015-12-31 | Skr2.38 Million ≈ $256.40K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Luxbright AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 201748800.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr16.27 Million | 60.49% |
| Other Components | Skr10.63 Million | 39.51% |
| Total Equity | Skr26.89 Million | 100.00% |
Luxbright AB Competitors by Market Cap
The table below lists competitors of Luxbright AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CPT GLOBAL LTD
F:714
|
$2.11 Million |
|
Fluicell AB
ST:FLUI
|
$2.11 Million |
|
International Prospect Ventures Ltd
V:IZZ
|
$2.11 Million |
|
Martello Technologies Group Inc
V:MTLO
|
$2.11 Million |
|
CCSC Technology International Holdings Limited Ordinary Shares
NASDAQ:CCTG
|
$2.10 Million |
|
Propanc Biopharma, Inc. Common Stock
NASDAQ:PPCB
|
$2.10 Million |
|
AFC Energy plc
LSE:AFC
|
$2.10 Million |
|
Nextferm Technologies Ltd
TA:NXFR
|
$2.09 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Luxbright AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 34,197,000 to 26,895,000, a change of -7,302,000 (-21.4%).
- Net loss of 19,464,000 reduced equity.
- Other comprehensive income decreased equity by 6,373,602.
- Other factors increased equity by 18,535,602.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr-19.46 Million | -72.37% |
| Other Comprehensive Income | Skr-6.37 Million | -23.7% |
| Other Changes | Skr18.54 Million | +68.92% |
| Total Change | Skr- | -21.35% |
Book Value vs Market Value Analysis
This analysis compares Luxbright AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.68x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.92x to 0.68x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | Skr0.08 | Skr0.15 | x |
| 2016-12-31 | Skr-0.02 | Skr0.15 | x |
| 2017-12-31 | Skr-0.20 | Skr0.15 | x |
| 2018-12-31 | Skr0.24 | Skr0.15 | x |
| 2019-12-31 | Skr0.34 | Skr0.15 | x |
| 2020-12-31 | Skr1.27 | Skr0.15 | x |
| 2021-12-31 | Skr0.68 | Skr0.15 | x |
| 2022-12-31 | Skr0.71 | Skr0.15 | x |
| 2023-12-31 | Skr0.49 | Skr0.15 | x |
| 2024-12-31 | Skr0.33 | Skr0.15 | x |
| 2025-12-31 | Skr0.22 | Skr0.15 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Luxbright AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -72.37%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -170.51%
- • Asset Turnover: 0.29x
- • Equity Multiplier: 1.46x
- Recent ROE (-72.37%) is below the historical average (-67.19%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | -64.86% | -1818.60% | 0.02x | 2.02x | Skr-1.78 Million |
| 2016 | 0.00% | -427.73% | 0.06x | 0.00x | Skr-3.05 Million |
| 2017 | 0.00% | -566.98% | 0.13x | 0.00x | Skr-6.34 Million |
| 2018 | -177.67% | -875.41% | 0.09x | 2.18x | Skr-12.95 Million |
| 2019 | -101.46% | -1514.10% | 0.05x | 1.47x | Skr-11.70 Million |
| 2020 | -32.05% | -2015.86% | 0.01x | 1.14x | Skr-16.25 Million |
| 2021 | -87.73% | -2482.59% | 0.03x | 1.16x | Skr-20.16 Million |
| 2022 | -75.84% | -2603.66% | 0.03x | 1.12x | Skr-23.92 Million |
| 2023 | -75.33% | -2968.90% | 0.02x | 1.21x | Skr-28.74 Million |
| 2024 | -51.81% | -196.38% | 0.21x | 1.25x | Skr-21.14 Million |
| 2025 | -72.37% | -170.51% | 0.29x | 1.46x | Skr-22.15 Million |
Industry Comparison
This section compares Luxbright AB's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $171,567,428
- Average return on equity (ROE) among peers: -27.92%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Luxbright AB (LXB) | Skr26.89 Million | -64.86% | 0.46x | $2.10 Million |
| Acarix A/S (ACARIX) | $15.12 Million | -127.02% | 0.21x | $33.84 Million |
| Arcoma AB (ARCOMA) | $48.66 Million | 5.27% | 0.68x | $11.55 Million |
| Bactiguard Holding AB (publ) (BACTI-B) | $387.11 Million | -0.84% | 0.62x | $61.64 Million |
| BICO Group AB (BICO) | $2.31 Million | 0.00% | 2.47x | $159.82 Million |
| Boule Diagnostics AB (BOUL) | $295.74 Million | 7.87% | 0.93x | $14.38 Million |
| CellaVision AB (CEVI) | $887.58 Million | 17.25% | 0.23x | $311.10 Million |
| Clinical Laserthermia Systems AB (publ) (CLS-B) | $26.09 Million | -70.24% | 0.12x | $11.57 Million |
| Chordate Medical Holding AB (CMH) | $25.64 Million | -77.06% | 0.22x | $29.05K |
| C-Rad AB (publ) (CRAD-B) | $29.82 Million | -34.38% | 0.50x | $86.08 Million |
| Duearity AB (DEAR) | $-2.39 Million | 0.00% | 0.00x | $331.97K |
About Luxbright AB
Luxbright AB (publ), a technology company, develops, manufactures, and sells microfocus x-ray tubes and sources for industrial and non-destructive testing applications worldwide. It also provides Luxbright IX1, an integrated x-ray source product; and custom-made x-ray tubes. Luxbright AB (publ) was incorporated in 2012 and is headquartered in Västra Frölunda, Sweden.